<DOC>
	<DOCNO>NCT02419807</DOCNO>
	<brief_summary>This clinical trial enroll 130 adult woman confirm diagnosis clinical stage 1 2 breast cancer undergo breast cancer surgery lumpectomy mastectomy plan axillary sentinel node biopsy procedure . Patients undergo lymphatic mapping technetium Tc-99m ( 99mTc ) sulfur colloid accordance routine clinical practice . Injections 99mTc sulfur colloid take place afternoon prior plan next morning surgery morning surgery . Patients undergo lymphoscintigraphy accordance standard clinical practice . Immediately prior operation , induction anesthesia operating room , 1cc 0.5 % indocyanine green ( ICG ) solution inject subdermally close tumor subareolar region disinfection breast skin . ICG movement facilitate manual massage monitor fluorescence imaging . ICG fluorescence elicit detected Photodynamic Eye ( PDE ) camera . The lymphatic drainage , make evident fluorescent dye , monitor real time monitor . The fluorescence follow towards armpit region ( axilla ) time fluorescence reach axilla record . Following standard practice , incision make armpit region . Fluorescent lymph node ( ICG positive ) localize remove analyzed pathologist . Node removal continue residual fluorescence visible axilla . Removed nodes test radioactivity use standard gamma-detecting probe count per minute record . Finally , armpit region inspect gamma probe determine residual radioactive node . Residual sentinel node ( first node receive lymph tumor ) remove . For purpose study , sentinel status node define flagged sentinel either one ICG 99mTc method . The goal project confirm axillary lymphatic mapping ICG lead similar node label sentinel lymphatic map 99mTc-labeled radiotracer .</brief_summary>
	<brief_title>Comparison Use Indocyanine Green 99mTc-labeled Radiotracer Axillary Lymphatic Mapping Patients With Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To confirm axillary lymphatic mapping indocyanine green solution ( ICG ) solution lead similar number node label sentinel lymphatic map 99mTc-labeled ( technetium Tc-99m sulfur colloid ) radiotracer . OUTLINE : Patients receive technetium Tc-99m sulfur colloid injection undergo lymphoscintigraphy accord clinical practice . Prior surgery , patient also receive indocyanine green solution subdermally close tumor subareolar region breast skin . Patients undergo axillary sentinel node biopsy surgery .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>Patients confirm diagnosis clinical stage 1 2 breast cancer Patients undergo breast cancer surgery lumpectomy mastectomy Patients plan axillary sentinel node biopsy procedure Patients cancer &gt; 3 cm Patients clinically positive node Patients prior surgery breast cancer index breast Patiens bilateral breast surgery Thyroid dysfunction Hypersensitivity iodine Hepatic insufficiency Renal insufficiency</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Near Infrared Fluorescence Imaging</keyword>
	<keyword>Indocyanine Green</keyword>
	<keyword>axillary lymph node mapping</keyword>
	<keyword>Mastectomy , Segmental</keyword>
	<keyword>Sentinel Lymph Node Biopsy</keyword>
	<keyword>Lumpectomy</keyword>
</DOC>